Breaking News Instant updates and real-time market news.

IRIX

Iridex

$5.25

-0.235 (-4.29%)

09:05
10/12/18
10/12
09:05
10/12/18
09:05

IRIDEX transferred with a Buy at Roth Capital

Roth Capital transferred coverage of IRIDEX to analyst David Solomon, who maintains a Buy rating but lowered the price target on the stock to $10 from $11. G6 probes are forecasted to drive about 20% top-line growth from FY19-FY23, with gross margins forecasted to expand to 60-65% by FY23, which could drive substantial earnings growth, Solomon tells investors.

IRIX Iridex
$5.25

-0.235 (-4.29%)

08/31/18
ROTH
08/31/18
NO CHANGE
ROTH
Buy
IRIDEX showing material progress in KOL-driven strategy, says Roth Capital
After IRIDEX announced that U.S. News and World Report said that 35 of the top 39 "Best Hospitals for Ophthalmology" currently use the Cyclo G6 Glaucoma Laser System, Roth Capital analyst Scott Henry said he was encouraged to learn that the extent to which leading centers had been using the system is broader than he previously assumed. The analyst, who sees this as evidence of the material progress IRIDEX is making in executing its Key Opinion Leader, or KOL, driven commercial strategy, maintains a Buy rating on the shares.
11/03/17
11/03/17
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. YogaWorks (YOGA) initiated with an Outperform at Imperial Capital. 2. IRIDEX (IRIX) resumed with a Buy at Roth Capital. 3. TE Connectivity (TEL) initiated with an Outperform at Baird. 4. Pilgrim's Pride (PPC), Sanderson Farms (SAFM), and Tyson Foods (TSN) were initiated with an Equal Weight at Morgan Stanley, while Hormel Foods (HRL) initiated with an Underweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/03/17
ROTH
11/03/17
INITIATION
Target $13
ROTH
Buy
IRIDEX resumed with a Buy at Roth Capital
Roth Capital analyst Scott Henry resumed coverage of IRIDEX with a Buy rating and $13 price target.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.